Citylife > Press Release
  Home Contact us Add to Favourites
Most Recent Postings
More Press Releses
Featured Sections

Event Finder
A daily roundup of exhibitions, promotions and other events in Dubai and the rest of the Emirates.
Submit an Event
Latest Dubai Press Releases >> Healthcare, Fitness and Medicine

  • UAE is among the first countries in the world to introduce the first targeted biologics
  • The incidence of atopic dermatitis has increased by 2- to 3-fold during the past decades in industrialized countries 
Dubai, UAE, 11 March 2018 –   Under the patronage of the Emirates Dermatology Society, Sanofi today announced the launch of an innovative therapy, that is seen to significantly help adults with moderate-to-severe atopic dermatitis (AD). After receiving a fast-track approval by the Ministry of Health & Prevention, UAE is one of the first few countries in the world to make the therapy available to patients. 
“Launching healthcare innovations in the UAE is high on the agenda of the Ministry of Health & Prevention, and we have taken significant steps in the past years to accelerate availability of innovations and breakthrough that improve people's life and enhance their happiness. We are indeed driven by the vision of our beloved country leaders who want people living in our beautiful country to enjoy highest standards of life,” said His Excellency Dr. Amin Al Amiri,  Asst. Undersecretary for Public Health Policy and License Sector in UAE Ministry of Health & Prevention. 
Atopic dermatitis, a form of eczema, is a chronic inflammatory disease with symptoms often appearing as a rash on the skin. , , ,  It is caused, in part, by an underlying inflammation in the body that is believed to be driven by an overactive immune system. Moderate-to-severe atopic dermatitis is characterized by rashes often covering much of the body, and can include intense, persistent itching and skin dryness, cracking, redness, crusting, and oozing. ,  Itch is one of the most difficult symptoms for patients and can be severely debilitating.7 In addition, they experience impaired quality of life, including disrupted sleep, and increased anxiety and depression symptoms along with their disease. 
“People with moderate-to-severe atopic dermatitis can experience unbearable symptoms. Most of them endure uncontrollable itch and bleeding lesions. So, to say that this condition negatively impacts their quality of life is an understatement,” said Dr. Anwar Al Hammadi, Consultant and Head of Dermatology at Dubai Health Authority and President of Emirates Dermatology Society. “Patients struggle to effectively control their disease with the treatment options currently available.”
The new therapy  introduced is jointly developed by Sanofi and Regeneron under a global collaboration agreement. It is a first-in-class biologic medicine approved by the European Commission (EC) to treat adults with moderate-to-severe atopic dermatitis (AD) who are candidates for systemic therapy.  The EC approval of the medicine was based on data from the global LIBERTY AD clinical trial program that included approximately 2,800 adults living with this serious disease.      It has demonstrated a significant reduction in the signs and symptoms of the disease and improvement in quality of life. 
“As physicians, we welcome the timely access to this important new medication to help provide patients relief from this severely debilitating condition. As members of the UAE society, we all have a vital role to play towards raising more awareness; and hence, creating better understanding of what people with the condition go through,” added Dr. Al Hammadi.
Attendees at the press conference launch had the unique opportunity to experience the impact of atopic dermatitis through an art installation that captured an emotional journey through testimonials, real feelings and stories of people living with the condition. 
The announcement comes ahead of the medical launch of the innovative therapy for healthcare professionals on 9 March. It is expected to be attended by leading dermatologists in the country, along with global and regional experts.
“At Sanofi, it remains a key priority for us to bring first to the country innovative treatments, and to make sure that the most number of people to have access to them. The efforts of the UAE Ministry of Health to accelerate availability of new innovative treatments for the patients in the UAE is, indeed, remarkable,” said Jean Paul Scheuer, Country Chair and General Manager for Sanofi Gulf. The introduction of this therapy is an important milestone for people living with moderate-to-severe atopic dermatitis in UAE. 

Posted by : GoDubai Editorial Team
Viewed 5514 times
Posted on : Sunday, March 11, 2018  
Replication or redistribution in whole or in part is expressly prohibited without the prior written consent of GoDubai.com.
Previous Story : Spotlight on technological advancements at the 6th International Congress for Joint Reconstruction M...
Next Story : Arabian Healthcare Group and Dignity Health USA team up to expand world-class clinical excellence to...
Email this article Print this article

Share this article with your friends and followers


Back to Top  
Most Viewed Press Release posted in the last 7 days
Top Perfume Picks for Mother's Day @ Glambeaute.com
Filorga Launches Lift Range
Nissan's e-POWER technology wins environmental award
The Global Sensation UFO Lands in Europe at Cosmoprof 2018
Discover the MISA Cho Gong Jin Oriental and Herbal Skincare Range from Missha
Drink yourself to looking younger with Skinade
The V-Tox Facial by Linda Meredith Skincare
Mother's Day Offer from Blush N Curls Salon
It's Mother's Day!
Corporate Power Dressing redefined at Kachins Signature
Al-Futtaim Honda launches 10th generation Honda Accord
The only line you'll love in your face – your perfect jawline!
GMC sets a new GUINNESS WORLD RECORDS title in partnership with Abu Dhabi Police
ba&sh's Spring-Summer collection 2018
OMEGA Launches its NATO Strap “Pop-Up Boutique” in Paris
Raymond Weil introduces the Maestro Blues
Top Picks for Babies & Kids @ Glambeaute.com
GUESS Unveils the Kids Spring 2018 Collection and Campaign
Cadillac Alghanim kicks off world-class opportunity in Kuwait
A Meet & Greet with the Pakistani Cricket Sensation Umar Akmal
Beyond Beauty partners with Platinum Records to position teen sensation Hala Al ...
The Spring Summer 18 Womenswear Collection
Milan-san Remo a Dream Target as Uae Team Emirates Announce Super-seven Line Up
IKEA launches the OMEDELBAR limited-edition collection!
Awqaf and Minors Affairs Foundation Attracts 1200 Emirati Job Seekers at Careers...
Samsung Mother's Day Blurbs 2018
The Collection by Phuong Dang
Her Highness Sheikha Latifa bint Mohammed bin Rashid Al Maktoum Inaugurates SIKK...
Join the UAEs first Women's Warrior Challenge.
Scuderia Ferrari Father & Son Gift Set
From Jade to Diamond
SOUQ welcomes 3M's innovative products to serve everyday customer needs
Chloé Reinterprets the Iconic “Carlina” Sunglass With an Exclusive Twist Motif
The era of Quiet Rebels
Lufthansa Group achieves best result in its history
Agreement signed in the presence of His Highness Sheikh Mohammed Bin Zayed Al Na...
Business of beauty goes green at Beautyworld Middle East 2018 as Natural & Organ...
2XL launches “Caspar” living room collection in grey
Dubai WoodShow takes off with more than 300 exhibitors from 55 countries and six...
Galeries Lafayette Le Gourmet Food Fest returns back to City Walk
10 Must-see Activities at Dubai International Horse Fair This Week
TAG Heuer Continues its Automotive Legacy On & Off the Track with 3 New Contempo...
Turkish Airlines Closes Airbus and Boeing Orders
Blackberry® Keyone Bronze Edition Available Now in the Middle East
The Bremont 1918 Limited Edition Collection
LACOSTE reveals a new feminine watch collection - the Kea family!
Keventers unveils Kids Special Menu for Mother's Day
Emirati woman grabs first place in women's category of 18th Fazza Open Champions...
Boss watches presents Magnitude collection – a new angle on time!